Most recently, American researchers have started to establish a link between filler injections and how they can trigger potentially deadly inflammation in the kidneys.

AbbVie's 2020 acquisition of Allergan made it a top player in the aesthetics market as well, with top-sellers including Botox and Juvederm. You can pick up one share of AbbVie for around $212 as ...